Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Clinical Investigation
Utility of Serum Ratio of Heart-Type Fatty Acid-Binding Protein to Myoglobin for Cardiac Damage Regardless of Renal Dysfunction
Masato FuruhashiNobuyuki UraKoichi HasegawaKazufumi TsuchihashiTomoaki NakataKazuaki Shimamoto
著者情報
ジャーナル フリー

2004 年 68 巻 7 号 p. 656-659

詳細
抄録
Background The serum ratio of heart-type fatty acid-binding protein to myoglobin (F/M) has been shown to be a new marker for cardiac damage and volume overload in hemodialysis patients. We evaluated the utility of F/M in hemodialysis patients compared to control subjects. Methods and Results Twenty-one hemodialysis patients and 17 control subjects with normal renal function were investigated. Using a cutoff point of mean + 2SD of the F/M in the controls (value: 0.147), the hemodialysis patients were divided into 2 groups. The concentrations of atrial natriuretic peptide (ANP) and brain natriuretic peptide after hemodialysis in the high F/M group were higher than those in the low F/M group. The mean level of ANP in the low F/M group was almost the upper limit of normal range. The values of left ventricular end-diastolic dimension and left ventricular mass index in the high F/M group were higher than those in the low F/M group, and the mean levels of those in the low F/M group were almost the same as those in the controls. Conclusions The F/M can be evaluated by the absolute value regardless of renal dysfunction, and the value of 0.147 might be useful for determining the cutoff level of cardiac involvement. (Circ J 2004; 68: 656 - 659)
著者関連情報
© 2004 THE JAPANESE CIRCULATION SOCIETY
前の記事 次の記事
feedback
Top